Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.

Tim Heise Helle LinnebjergDavid CoutantElizabeth LaBellEric Zijlstra Christoph Kapitza Juliana M Bue-ValleskeyQianyi ZhangMary Anne DellvaJennifer Leohr

Published in: Diabetes, obesity & metabolism (2020)

URLi demonstrated the fastest insulin absorption and the greatest numeric PPG-lowering effect compared to the other insulins tested. URLi more closely matched the early physiological glucose control observed in healthy subjects.

Keyphrases

blood glucose
type diabetes
glycemic control
open label
double blind
loop mediated isothermal amplification
high resolution
clinical trial
blood pressure
phase iii
randomized controlled trial
weight loss
metabolic syndrome
quantum dots